Nogo-A Expression in the Human Hippocampus in Normal Aging and in Alzheimer Disease

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of Neuropathology and Experimental Neurology

• Publication date

  2006-05-01

• Fields of study

  Biology, Medicine, Psychology

• Identifiers
  DOI 10.1097/01.jnen.0000222894.59293.98PMID 16772867
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Alzheimer type dementia].

  2008cited by this paper
• Expression pattern of NOGO-A protein in the human nervous system

  2005cited by this paper
• Nogo-A, -B, and -C Are Found on the Cell Surface and Interact Together in Many Different Cell Types*

  2005cited by this paper
• ReportA TNF Receptor Family Member , TROY , Is a Coreceptor with Nogo Receptor in Mediating the Inhibitory Activity of Myelin Inhibitors

  2005cited by this paper
• The 14-3-3 Protein Forms a Molecular Complex with Heat Shock Protein Hsp60 and Cellular Prion Protein

  2005cited by this paper
• Nogo CAA 3'UTR Insertion polymorphism is not associated with Schizophrenia nor with bipolar disorder.

  2005cited by this paper
• Overexpression of myelin-associated glycoprotein after axotomy of the perforant pathway.

  2005cited by this paper
• TAJ/TROY, an orphan TNF receptor family member, binds Nogo-66 receptor 1 and regulates axonal regeneration.

  2005cited by this paper
• CAA insertion polymorphism in the 3'UTR of Nogo gene on 2p14 is not associated with schizophrenia.

  2005cited by this paper
• A TNF receptor family member, TROY, is a coreceptor with Nogo receptor in mediating the inhibitory activity of myelin inhibitors.

  2005cited by this paper
• Experience-Driven Plasticity of Visual Cortex Limited by Myelin and Nogo Receptor

  2005cited by this paper
• Expression pattern of NOGO and NgR genes during human development.

  2005cited by this paper
• Nogo-A and Nogo Receptor Expression in Demyelinating Lesions of Multiple Sclerosis

  2005cited by this paper
• Vesicular glutamate transporter 1 immunostaining in the normal and epileptic human cerebral cortex.

  2005cited by this paper
• Reticulon family members modulate BACE1 activity and amyloid-β peptide generation

  2004cited by this paper
• LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex

  2004cited by this paper
• Regulation of Nogo and Nogo receptor during the development of the entorhino-hippocampal pathway and after adult hippocampal lesions.

  2004cited by this paper
• Dynamics of oligodendrocyte responses to anterograde axonal (Wallerian) and terminal degeneration in normal and TNF‐transgenic mice

  2004cited by this paper
• Entorhinal Cortex Lesion in the Mouse Induces Transsynaptic Death of Perforant Path Target Neurons

  2004cited by this paper
• Identification of two NOGO/RTN4 genes and analysis of Nogo-A expression in Xenopus laevis.

  2004cited by this paper
• Neuronal activity-induced regulation of Lingo-1

  2004cited by this paper
• Increased expression of Nogo‐A in hippocampal neurons of patients with temporal lobe epilepsy

  2004cited by this paper
• Oligodendrocyte degeneration in AD.

  2004cited by this paper
• Multi-functional gene ASY/Nogo/RTN-X/RTN4: Apoptosis, tumor suppression, and inhibition of neuronal regeneration

  2004cited by this paper
• A novel drug target in Alzheimer's disease.

  2004cited by this paper
• Relationships between arteriosclerosis, cerebral amyloid angiopathy and myelin loss from cerebral cortical white matter in Alzheimer's disease

  2004cited by this paper
• The possible role of myelin destruction as a precipitating event in Alzheimer's disease.

  2004cited by this paper
• Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders

  2004cited by this paper
• Abeta42 generation is toxic to endothelial cells and inhibits eNOS function through an Akt/GSK-3beta signaling-dependent mechanism.

  2003cited by this paper
• Molecular analysis of Nogo expression in the hippocampus during development and following lesion and seizure 1

  2003cited by this paper
• Intraneuronal localization of Nogo‐A in the rat

  2003cited by this paper
• Nogo and its paRTNers.

  2003cited by this paper
• Oligodendrocytes Promote Neuronal Survival and Axonal Length by Distinct Intracellular Mechanisms: A Novel Role for Oligodendrocyte-Derived Glial Cell Line-Derived Neurotrophic Factor

  2003cited by this paper
• The Trophic Role of Oligodendrocytes in the Basal Forebrain

  2003cited by this paper
• Reactive Synaptogenesis in Aging and Alzheimer's Disease: Lessons Learned in the Cotman Laboratory

  2003cited by this paper
• Activity-induced and developmental downregulation of the Nogo receptor

  2003cited by this paper
• Electron microscopic localization of Nogo-A at the postsynaptic active zone of the rat.

  2003cited by this paper
• Functional Reorganization of the Motor Cortex in Adult Rats after Cortical Lesion and Treatment with Monoclonal Antibody IN-1

  2003cited by this paper
• Extracellular matrix of different composition supports the various splenic compartments of guinea fowl (Numida meleagris)

  2003cited by this paper
• Aβ42 generation is toxic to endothelial cells and inhibits eNOS function through an Akt/GSK-3β signaling-dependent mechanism

  2003cited by this paper
• Patterns of Nogo mRNA and Protein Expression in the Developing and Adult Rat and After CNS Lesions

  2002cited by this paper
• Nogo-A expression in mature oligodendrocytes of rat spinal cord in association with specific molecules.

  2002cited by this paper
• Nogo provides a molecular marker for diagnosis of amyotrophic lateral sclerosis.

  2002cited by this paper
• p75 interacts with the Nogo receptor as a co-receptor for Nogo, MAG and OMgp

  2002cited by this paper
• Schizophrenia and Nogo: elevated mRNA in cortex, and high prevalence of a homozygous CAA insert.

  2002cited by this paper
• Identification and characterization of a novel Nogo‐interacting mitochondrial protein (NIMP)

  2002cited by this paper
• Expression of Nogo protein by growing axons in the developing nervous system.

  2002cited by this paper
• Increased Aβ Peptides and Reduced Cholesterol and Myelin Proteins Characterize White Matter Degeneration in Alzheimer's Disease†

  2002cited by this paper
• Localization of Nogo-A and Nogo-66 Receptor Proteins at Sites of Axon–Myelin and Synaptic Contact

  2002cited by this paper
• Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth

  2002cited by this paper
• Oligodendrocyte‐myelin glycoprotein (OMgp) is an inhibitor of neurite outgrowth

  2002cited by this paper
• Nogo‐receptor gene activity: Cellular localization and developmental regulation of mRNA in mice and humans

  2002cited by this paper
• Increased A beta peptides and reduced cholesterol and myelin proteins characterize white matter degeneration in Alzheimer's disease.

  2002cited by this paper
• Caenorhabditis elegans reticulon interacts with RME-1 during embryogenesis.

  2002cited by this paper
• Amyloid-β Peptides Are Cytotoxic to Oligodendrocytes

  2001cited by this paper
• A role for oligodendrocyte‐derived IGF‐1 in trophic support of cortical neurons

  2001cited by this paper
• NOGO mRNA expression in adult and fetal human and rat nervous tissue and in weight drop injury.

  2001cited by this paper
• Focal cerebral ischemia induces increased myelin basic protein and growth-associated protein-43 gene transcription in peri-infarct areas in the rat brain

  2001cited by this paper
• Neuronal plasticity and formation of new synaptic contacts follow pyramidal lesions and neutralization of Nogo‐A: A light and electron microscopic study in the pontine nuclei of adult rats

  2001cited by this paper
• Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein

  2000cited by this paper
• A novel protein, RTN-xS, interacts with both Bcl-xL and Bcl-2 on endoplasmic reticulum and reduces their anti-apoptotic activity

  2000cited by this paper
• Neurobiology: Inhibitor of neurite outgrowth in humans

  2000cited by this paper
• Carnosine-related dipeptides in neurons and glia.

  2000cited by this paper
• Slowed recovery of rod photoresponse in mice lacking the GTPase accelerating protein RGS9-1

  2000cited by this paper
• Vulnerability of Select Neuronal Types to Alzheimer's Disease

  2000cited by this paper
• Application of Neutralizing Antibodies against NI-35/250 Myelin-Associated Neurite Growth Inhibitory Proteins to the Adult Rat Cerebellum Induces Sprouting of Uninjured Purkinje Cell Axons

  2000cited by this paper
• Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1

  2000cited by this paper
• Axonal sprouting regulates myelin basic protein gene expression in denervated mouse hippocampus

  2000cited by this paper
• Temporal Sequence of Alzheimer’s Disease-Related Pathology

  1999cited by this paper
• Neurodegenerative and age-related changes in structure and function of cerebral cortex

  1999cited by this paper
• Translating cell biology into therapeutic advances in Alzheimer's disease

  1999cited by this paper
• Microtechnology: Laying it on thick

  1999cited by this paper
• Molecular Isoform Distribution and Glycosylation of Acetylcholinesterase Are Altered in Brain and Cerebrospinal Fluid of Patients with Alzheimer’s Disease

  1999cited by this paper
• Evolution of neuronal changes in the course of Alzheimer's disease.

  1998cited by this paper
• Identification of the glial cell types containing carnosine-related peptides in the rat brain.

  1997cited by this paper
• Amyloid Fibril Toxicity in Alzheimer's Disease and Diabetes a

  1996cited by this paper
• Identification of myelin-associated glycoprotein as a major myelin-derived inhibitor of neurite growth.

  1994cited by this paper
• A novel role for myelin-associated glycoprotein as an inhibitor of axonal regeneration.

  1994cited by this paper
• In vivo neurotoxicity of beta-amyloid [beta(1-40)] and the beta(25-35) fragment.

  1992cited by this paper
• In vivo neurotoxicity of beta-amyloid [β(1–40)] and the β(25–35) fragment

  1992cited by this paper
• Carnosine in the brain and olfactory system of amphibia and reptilia: a comparative study using immunocytochemical and biochemical methods.

  1991cited by this paper
• Cellular localization of carnosine-like and anserine-like immunoreactivities in rodent and avian central nervous system.

  1990cited by this paper
• Decreased myelin lipids in Alzheimer's disease and vascular dementia

  1989cited by this paper
• Overexpression of the myelin basic protein RNA in the cortex of a patient with Alzheimer's disease.

  1989cited by this paper
• Synaptic plasticity and functional stabilization in the hippocampal formation: possible role in Alzheimer's disease.

  1988cited by this paper
• Demyelination and remyelination in the rat central nervous system following ethidium bromide injection.

  1979cited by this paper
• Remyelination of the superior cerebellar peduncle in the mouse following demyelination induced by feeding cuprizone.

  1973cited by this paper

• Nogo-A Protein Mediates Oxidative Stress and Synaptic Damage Induced by High-Altitude Hypoxia in the Rat Hippocampus.

  2025cites this paper
• Analyses of Nogo-Family Genes in Mouse and Human Microglia Omics Datasets Identify LINGO1 as a Candidate Drug Target in Alzheimer’s Disease

  2025cites this paper
• Synapses tagged, memories kept: synaptic tagging and capture hypothesis in brain health and disease

  2024cites this paper
• Nogo-A Drives Alzheimer’s Disease Progression by Inducing Tauopathy Vulnerability

  2024cites this paper
• Intranasal Nose-to-Brain Drug Delivery via the Olfactory Region in Mice: Two In-Depth Protocols for Region-Specific Intranasal Application of Antibodies and for Expression Analysis of Fc Receptors via In Situ Hybridization in the Nasal Mucosa.

  2024cites this paper
• Microscale marvels: unveiling the macroscopic significance of micropeptides in human health.

  2024cites this paper
• The RhoA-ROCK1/ROCK2 Pathway Exacerbates Inflammatory Signaling in Immortalized and Primary Microglia

  2023cites this paper
• Reduction of NgR in perforant path protects neuronal morphology and function in APP/PS1 transgenic mice

  2023cites this paper
• Unveiling the modulation of Nogo Receptor in Neuroregeneration and plasticity: Novel aspects and future horizon in a new frontier.

  2023cites this paper
• Behavioral stress and antidepressant treatments altered hippocampal expression of Nogo signal-related proteins in rats.

  2023cites this paper
• Microglial Nogo delays recovery following traumatic brain injury in mice.

  2023cites this paper
• Modulation of the Microglial Nogo-A/NgR Signaling Pathway as a Therapeutic Target for Multiple Sclerosis

  2022cites this paper
• Inhibition of Nogo-A rescues synaptic plasticity and associativity in APP/PS1 animal model of Alzheimer's disease.

  2022cites this paper
• An Rtn4/Nogo-A-interacting micropeptide modulates synaptic plasticity with age

  2022cites this paper
• Zinc Ameliorates Nogo-A Receptor and Osteocalcin Gene Expression in Memory-Sensitive Rat Hippocampus Impaired by Intracerebroventricular Injection of Streptozotocin

  2022influential citation
• Reticulon 2 promotes gastric cancer metastasis via activating endoplasmic reticulum Ca2+ efflux-mediated ERK signalling

  2022cites this paper
• Nogo receptor impairs the clearance of fibril amyloid‐β by microglia and accelerates Alzheimer’s‐like disease progression

  2021cites this paper
• Selective CNS Targeting and Distribution with a Refined Region-Specific Intranasal Delivery Technique via the Olfactory Mucosa

  2021cites this paper
• Nogo-66 promotes β-amyloid protein secretion via NgR/ROCK-dependent BACE1 activation

  2021influential citation
• Effects of Pyruvate Administration on Mitochondrial Enzymes, Neurological Behaviors, and Neurodegeneration after Traumatic Brain Injury

  2021cites this paper
• Functional, Behavioral and Morphological Changes in the Rat Model of Parkinson’s Disease: Protective Effect of Curcumine

  2021cites this paper
• Co-Expression of Nogo-A in Dopaminergic Neurons of the Human Substantia Nigra Pars Compacta Is Reduced in Parkinson’s Disease

  2021cites this paper
• The Clinical Significance of Cerebrospinal Fluid Reticulon 4 (RTN4) Levels in the Differential Diagnosis of Neurodegenerative Diseases

  2021cites this paper
• Fasudil reduces β-amyloid levels and neuronal apoptosis in APP/PS1 transgenic mice via inhibition of the Nogo-A/NgR/RhoA signaling axis.

  2020cites this paper
• Nogo-A/S1PR2 signaling pathway inactivation decreases microvascular damage and enhances microvascular regeneration in PDMCI mice.

  2020cites this paper
• Significant association between GPR50 hypomethylation and AD in males

  2019cites this paper
• Regionally specified human pluripotent stem cell-derived astrocytes exhibit different molecular signatures and functional properties

  2019cites this paper
• Changes of myelin basic protein in the hippocampus of an animal model of type 2 diabetes

  2018cites this paper
• The adhesion and migration of microglia to β-amyloid (Aβ) is decreased with aging and inhibited by Nogo/NgR pathway

  2018cites this paper
• Nogo-A in the visual system development and in ocular diseases.

  2017cites this paper
• Spatiotemporal and Long Lasting Modulation of 11 Key Nogo Signaling Genes in Response to Strong Neuroexcitation

  2017cites this paper
• The emerging role of GPR50 receptor in brain.

  2016cites this paper
• The blockage of the Nogo/NgR signal pathway in microglia alleviates the formation of Aβ plaques and tau phosphorylation in APP/PS1 transgenic mice

  2016cites this paper
• New Insights into the Roles of Nogo-A in CNS Biology and Diseases

  2015cites this paper
• Identi fi cation of MANF as a protein interacting with RTN 1-C

  2015cites this paper
• Function of Nogo‐A/Nogo‐A Receptor in Alzheimer's Disease

  2015cites this paper
• Loss of Nogo-A-expressing neurons in a rat model of Parkinson's disease.

  2015cites this paper
• Identification of MANF as a protein interacting with RTN1-C.

  2015cites this paper
• The Nogo/Nogo Receptor (NgR) Signal Is Involved in Neuroinflammation through the Regulation of Microglial Inflammatory Activation*

  2015cites this paper
• Myelin-Associated Inhibitors in Axonal Growth after Central Nervous System Injury

  2015cites this paper
• Modulación de las propiedades migratorias de las células de la glia envolvente

  2015cites this paper
• Specific multi-nutrient enriched diet enhances hippocampal cholinergic transmission in aged rats.

  2015cites this paper
• Chronic cocaine administration causes extensive white matter damage in brain: diffusion tensor imaging and immunohistochemistry studies.

  2014cites this paper
• Effects of curcumin on hippocampal expression of NgR and axonal regeneration in Aβ-induced cognitive disorder rats.

  2014cites this paper
• Minocycline but not valproic acid influence the density of NogoA-immunoreactive neurons in the hilus of the dentate gyrus of the rats subjected to intracerebral haematoma

  2014cites this paper
• Proteomic response to metabolic stress and cellular dysfunction in relation to Alzheimer's disease

  2014cites this paper
• N-Methyl-d-Aspartate Receptor – Nitric Oxide Synthase Pathway in the Cortex of Nogo-A-Deficient Rats in Relation to Brain Laterality and Schizophrenia

  2013cites this paper
• Infusion of anti-Nogo-A antibodies in adult rats increases growth and synapse related proteins in the absence of behavioral alterations.

  2013influential citation
• Reticulon1-C modulates protein disulphide isomerase function

  2013cites this paper
• Adaptive changes in the neuronal proteome: mitochondrial energy production, endoplasmic reticulum stress, and ribosomal dysfunction in the cellular response to metabolic stress

  2013cites this paper
• The Transcriptomic Response of Mixed Neuron-Glial Cell Cultures to 1,25-Dihydroxyvitamin D3 Includes Genes Limiting the Progression of Neurodegenerative Diseases

  2013cites this paper
• Neuronal Overexpression of Nogo Receptor 1 in APPswe/PSEN1(ΔE9) Mice Impairs Spatial Cognition Tasks without Influencing Plaque Formation

  2012cites this paper
• Expression of the Nogo-A System in Cortical Lesions of Pediatric Patients With Tuberous Sclerosis Complex and Focal Cortical Dysplasia Type IIb

  2012cites this paper
• Reticulon Protein-1C: A New Hope in the Treatment of Different Neuronal Diseases

  2012cites this paper
• Investigating the role of orphan GPR50 in normal brain function and mental illness

  2012cites this paper
• Hippocampal expression of myelin‐associated inhibitors is induced with age‐related cognitive decline and correlates with deficits of spatial learning and memory

  2012cites this paper
• The Expression Patterns of Nogo-A, Myelin Associated Glycoprotein and Oligodendrocyte Myelin Glycoprotein in the Retina After Ocular Hypertension

  2011cites this paper
• Role of nogo - a in the intact central nervous system: an in vivo and in vitro approach.

  2011cites this paper
• Neuronal Nogo‐A regulates glutamate receptor subunit expression in hippocampal neurons

  2011cites this paper
• Roles of p75NTR in the pathogenesis of Alzheimer's disease: a novel therapeutic target.

  2011cites this paper
• The Expression Patterns of Nogo-A , Myelin Associated Glycoprotein and Oligodendrocyte Myelin Glycoprotein in the Retina After Ocular Hypertension The Expression of Myelin Proteins in the Retina in Glaucoma

  2011cites this paper
• Emerging functions of myelin‐associated proteins during development, neuronal plasticity, and neurodegeneration

  2011cites this paper
• Nogo-66 receptor activation inhibits neurite outgrowth and increases β-amyloid protein secretion of cortical neurons.

  2011cites this paper
• Quantification of myelin loss in frontal lobe white matter in vascular dementia, Alzheimer’s disease, and dementia with Lewy bodies

  2010cites this paper
• The role of Interleukin-6 in nervous regeneration and functional recovery in organotypic hippocampal slice cultures

  2010cites this paper
• Application of Mutant IDH1 Antibody to Differentiate Diffuse Glioma From Nonneoplastic Central Nervous System Lesions and Therapy-induced Changes

  2010cites this paper
• Functions of Nogo proteins and their receptors in the nervous system

  2010cites this paper
• Developmental expression of the oligodendrocyte myelin glycoprotein in the mouse telencephalon.

  2010influential citation
• Pincher-generated Nogo-A signalosomes mediate growth cone collapse and retrograde transport

  2009cites this paper
• GPR50 interacts with neuronal NOGO-A and affects neurite outgrowth.

  2009cites this paper
• Neutralization of the membrane protein Nogo‐A enhances growth and reactive sprouting in established organotypic hippocampal slice cultures

  2008cites this paper
• Identification and structural mechanism for a novel interaction between a ubiquitin ligase WWP1 and Nogo-A, a key inhibitor for central nervous system regeneration.

  2008cites this paper
• Developmental analysis of Lingo‐1/Lern1 protein expression in the mouse brain: Interaction of its intracellular domain with Myt1l

  2008influential citation
• Nogo-A and Nogo-66 receptor in amyotrophic lateral sclerosis

  2008cites this paper
• Upregulation of CaMKIIβ and Nogo-C mRNA in schizophrenia and the prevalence of CAA insert in the 3'UTR of the Nogo gene.

  2008cites this paper
• Novel roles for Nogo receptor in inflammation and disease.

  2008cites this paper
• Reticulon‐1C acts as a molecular switch between endoplasmic reticulum stress and genotoxic cell death pathway in human neuroblastoma cells

  2007cites this paper
• Nogo receptor interacts with brain APP and Abeta to reduce pathologic changes in Alzheimer's transgenic mice.

  2007cites this paper
• NOGO is increased and binds to BACE1 in sporadic inclusion-body myositis and in AβPP-overexpressing cultured human muscle fibers

  2007influential citation